Radiopharmaceuticals Market Analysis on Growth and Business Opportunities 2017-2024| Cardinal Health, MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging and Bayer AG
According to Data Bridge Market Research new report “Radiopharmaceuticals Market gives rising open doors in the market and the future effect of significant drivers and difficulties and, bolster leaders in settling on practical business choices. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity."Global Radiopharmaceuticals Market" is predictable to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Click Here for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market
Recent Developments: Radiopharmaceuticals Market
Recent trends in the radiopharmaceuticals market such as growing disease which targeted cancer therapy, increasing awareness, expanding applications of molecular imaging, technological advancement, increasing trend of radio-labelled peptides and monoclonal antibodies for the diagnosis and treatment of cancer tumors and increasing use of SPECT & PET scans is expected to drive the market in the forecast period 2017 to 2024.
Radiopharmaceuticals are mostly used for treatment of cancer, bone pain, and thyroid cancer. In the U.S. cancer is second fatal disease whereas in the UK it is the leading cause of death. In most of the third world countries cancer appears much lower. Cancer is the second leading cause of death globally and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. In 2016, an estimated 1.6 million new cases of cancer was diagnosed in the United States and 0.5 million people died from the disease.
On the other hand, shorter half-life of radiopharmaceuticals, stringent regulatory guidelines and competition from conventional diagnostic procedures are some of the factors which may hinder the growth of radiopharmaceuticals market.
Any Specific Requirements? Questions? Ask to Our Industry Expert @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market
Market Segmentation:
The global market is segmented based on type, procedural volumes, application, sources, end-user, and geography.
On the basis of type, the global radiopharmaceuticals market is sub-segmented into
• Diagnostic
• Therapeutic radiopharmaceuticals.
In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.
On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into
1. Diagnostic procedure
• single-photon emission computed tomography (SPECT) radiopharmaceuticals
• positron emission tomography (PET) radiopharmaceuticals
2. Therapeutic procedures
• beta emitters
• alpha emitters
• brachy therapy
On the basis of application, the global radiopharmaceuticals market is sub-segmented into
1. diagnostic application
• single-photon emission computed tomography (SPECT) -
• positron emission tomography (PET)- oncology, cardiology, neurology and others
2. therapeutic application
• thyroid,
• bone metastasis,
• lymphoma,
• endocrine tumours
• others
On the basis of sources, the global radiopharmaceuticals market is sub-segmented into
• nuclear reactors
• cyclotrons
On the basis of end user, the global radiopharmaceuticals market is sub-segmented into
• hospitals,
• ambulatory surgical centers,
• diagnostic centers,
• cancer research institutes and
• others
In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.
Questions? We’ll Put You On The Right Path Request Analyst Call @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-radiopharmaceuticals-market
TABLE OF CONTENTS
1 INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL RADIOPHARMACEUTICALS MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL RADIOPHARMACEUTICALS SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. GLOBAL RADIOPHARMACEUTICALS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE GLOBAL RADIOPHARMACEUTICALSMARKET
5.4. MARKET REGULATORY SCENARIO BY COUNTRY
5.5. INTERVIEW KEY INSIGHTS
6 GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE
7 GLOBAL RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUMES
8 GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION
9 GLOBAL RADIOPHARMACEUTICALS MARKET, BY SOURCES
10 GLOBAL RADIOPHARMACEUTICALS MARKET, BY END-USER
11 GLOBAL RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY
12 GLOBAL RADIOPHARMACEUTICALS MARKET, COMPANY PROFILES
12.1 CARDINAL HEALTH INC.,
12.2 MALLINCKRODTPLC.,
12.3 GE HEALTHCARE,
12.4 LANTHEUS MEDICAL IMAGING INC.,
12.5 BAYER AG,
12.6 COMPANY A
12.7 COMPANY B
12.8 COMPANY C
12.9 COMPANY D
12.10 COMPANY E
12.11 COMPANY F
10.12 COMPANY G
10.13 COMPANY H
10.14 COMPANY I
10.15 COMPANY J
10.16 COMPANY K
10.17 COMPANY M
10.18 COMPANY N
10.19 COMPANY O
11 APPENDIX
12 ABOUT DATA BRIDGE MARKET RESEARCH
Request for Table of Content of Full Report @ http://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
Radiopharmaceuticals Market report give rising open doors in the market and the future effect of significant drivers and difficulties and, bolster leaders in settling on practical business choices. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities.
Top Challengers:
• Cardinal Health Inc.
• MallinckrodtPlc.
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging SpA
• Eczacibasi-Monrol Nuclear Products
• Nordion Inc.
• Advanced Accelerator Applications S.A.
• IBA Molecular Imaging
• Actinium Pharmaceuticals Inc.,
• Among others.
Read more about Report Visit @ http://databridgemarketresearch.com/reports/global-radiopharmaceuticals-market/
Related Report
North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024
North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/north-america-digital-health-monitoring-devices-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals Market Analysis on Growth and Business Opportunities 2017-2024| Cardinal Health, MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging and Bayer AG here
News-ID: 1043573 • Views: …
More Releases from Data Bridge Market Research
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period.
Market Overview
This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market…
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031.
Market Overview
Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind…
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Overview
Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which…
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand…
More Releases for Radiopharmaceuticals
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Diagnostic Radiopharmaceuticals Market 2021 | Detailed Report
According to Market Study Report, Diagnostic Radiopharmaceuticals Market provides a comprehensive analysis of the Diagnostic Radiopharmaceuticals Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Diagnostic Radiopharmaceuticals Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645020
The report provides a comprehensive analysis of…
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…